Lung Cancer
News
Washington Post Blasts Proliferation of ESAs for Anemia
News
FDA Approves REMS for Long-Acting Opioids
News
FDA Warns of QT Prolongation with Ondansetron Dose
Conference Coverage
FDG-PET Performs Poorly in Lung Cancer Diagnosis
News
Experimental Immunotherapy Makes Headway in Lung Cancer
Major Finding: The overall response rate was 18% and the PFS rate was 26% among 76 evaluable patients with advanced non–small cell lung cancer....
News
Genomics Project Begins to Unravel Squamous Cell Lung Cancer
Major Finding: Exome and RNA sequence analyses identified an average of 228 nonsilent mutations/tumor in patients with squamous cell carcinoma of...
News
Panel Rejects New Heparin for VTE Prevention in Cancer
News
Adding Carboplatin to Pemetrexed Buoys Survival in Lung Cancer Subset
Major Finding: Median overall survival increased from 5.6 months with pemetrexed alone to 9.1 months with the addition of carboplatin (HR, 0.57; P...
Conference Coverage
Docetaxel Bests Erlotinib in EGFR Wild-Type Lung Cancer
Major Finding: Medium progression-free survival was 3.4 months with docetaxel vs.
Conference Coverage
Selumetinib Cracks Door to Targeted Therapy for KRAS-Mutant NSCLC
Major Finding: The primary end point of overall survival was 5.2 months with docetaxel plus placebo and 9.4 months with docetaxel and selumetinib...
Conference Coverage
Pemetrexed Maintenance Extends Survival of Advanced Lung Cancer
Major Finding: Median overall survival from randomization was 13.9 months with pemetrexed maintenance plus best supportive care vs.